Research
Cellular
Tirzepatide may have potential therapeutic effects on metabolic dysfunction-associated steatohepatitis (MASH).
Tirzepatide could be explored as a treatment option for patients with MASH, pending further research.
GoodQualifiesmedium confidence
The available evidence suggests that it may have potential therapeutic effects on MASH.
Why this rating
The claim is based on available evidence, though not as robust as the primary claims.
Source
Tirzepatide in Treating Metabolic Disorders
Shulin Wei et al. · International Journal of Drug Discovery and Pharmacology · 2024
DOI 10.53941/ijddp.2024.100023
reviewCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →